IL120955A0 - Treatment of osteoporosis - Google Patents

Treatment of osteoporosis

Info

Publication number
IL120955A0
IL120955A0 IL12095597A IL12095597A IL120955A0 IL 120955 A0 IL120955 A0 IL 120955A0 IL 12095597 A IL12095597 A IL 12095597A IL 12095597 A IL12095597 A IL 12095597A IL 120955 A0 IL120955 A0 IL 120955A0
Authority
IL
Israel
Prior art keywords
osteoporosis
treatment
Prior art date
Application number
IL12095597A
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Priority to IL12095597A priority Critical patent/IL120955A0/en
Publication of IL120955A0 publication Critical patent/IL120955A0/en
Priority to AU75459/98A priority patent/AU7545998A/en
Priority to PCT/IL1998/000246 priority patent/WO1998053827A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
IL12095597A 1997-05-30 1997-05-30 Treatment of osteoporosis IL120955A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL12095597A IL120955A0 (en) 1997-05-30 1997-05-30 Treatment of osteoporosis
AU75459/98A AU7545998A (en) 1997-05-30 1998-05-28 Treatment of osteoporosis
PCT/IL1998/000246 WO1998053827A1 (en) 1997-05-30 1998-05-28 Treatment of osteoporosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12095597A IL120955A0 (en) 1997-05-30 1997-05-30 Treatment of osteoporosis

Publications (1)

Publication Number Publication Date
IL120955A0 true IL120955A0 (en) 1997-09-30

Family

ID=11070199

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12095597A IL120955A0 (en) 1997-05-30 1997-05-30 Treatment of osteoporosis

Country Status (3)

Country Link
AU (1) AU7545998A (en)
IL (1) IL120955A0 (en)
WO (1) WO1998053827A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
WO2017147420A1 (en) * 2016-02-25 2017-08-31 The University Of Florida Research Foundation, Inc. Methods and compositions with vitamin d compounds for treatment of cystic fibrosis and respiratory disorders
CN113181193A (en) * 2021-05-08 2021-07-30 黄彬 Application of calcipotriol as skin external-use medicine for preventing and treating senile osteoporosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330537A (en) * 1977-12-07 1982-05-18 The Procter & Gamble Company Compositions for inhibiting mobilization of calcium phosphate in animal tissue
IL74617A (en) * 1985-03-15 1988-11-15 Yeda Res & Dev Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals
US5317017A (en) * 1992-09-30 1994-05-31 Merck & Co., Inc. N-biphenyl-3-amido substituted benzolactams stimulate growth hormone release
GB2273046A (en) * 1992-12-02 1994-06-08 Merck & Co Inc Synergistic combination to improve secretion of endogenous growth hormone
US5606054A (en) * 1993-12-14 1997-02-25 Merck & Co., Inc. Heterocyclic-fused lactams promote release of growth hormone

Also Published As

Publication number Publication date
WO1998053827A1 (en) 1998-12-03
AU7545998A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
GB9407135D0 (en) Treatment of osteoporosis
PL328831A1 (en) Combined treatment of osteoporosis
ZA988886B (en) Formulation for treatment of osteoporosis
GB2335153B (en) Treatment of water
IL131484A0 (en) Treatment of cardiomyopathy
GB9700899D0 (en) Novel treatment
GB9715295D0 (en) Novel method of treatment
GB9712866D0 (en) Novel method of treatment
GB9707693D0 (en) Novel method of treatment
GB9725114D0 (en) Treatment of pruritus
EP1011698A4 (en) Chemical supplementation of bone
GB9715298D0 (en) Novel method of treatment
EP0981545A4 (en) Treatment of osteoporosis
GB9715306D0 (en) Novel method of treatment
GB2326116B (en) Treatment of chocolate
IL120955A0 (en) Treatment of osteoporosis
HUP0203741A3 (en) Treatment of osteoporosis
GB9721978D0 (en) Treatment of depression
PL346528A1 (en) Treatment of depression
PL327430A1 (en) Set of shaped components
SI1021194T1 (en) New improved formulation for treatment of osteoporosis
GB9721692D0 (en) Novel treatment
GB9708700D0 (en) Treatment of depression
GB9701448D0 (en) Methods of treatment
GB2322623B (en) Treatment of liquid

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)

Owner name: RAMOT AT TEL-AVIV UNIVERSITY LTD.

Free format text: FORMER NAMES:RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH AND INDUSTRIAL;DEVELOPMENT LTD.